Adipotide

Adipotide, scientifically known as Prohibitin-targeting peptide 1, is a peptidomimetic with the sequence CKGGRAKDC-GG-D(KLAKLAK)₂. It is an experimental proapoptotic drug that has been shown to cause rapid weight loss.

Adipotide, also known as FT-TP, is a peptide (Buy Peptides) that has gained attention for its potential role in weight loss and fat reduction. It was initially developed by researchers at the City of Hope National Medical Center. The peptide works by targeting adipose tissue (fat cells) and inducing apoptosis (programmed cell death) in those cells. FT-TP represents a breakthrough in fat loss technology, harnessing the potential of a peptidomimetic substance with a unique structural sequence of CKGGRAKDC-GG-D(KLAKLAK)2. By selectively targeting and shrinking adipose tissue fat, 

Key Facts about FT-TP

Current Research: Ongoing studies are focused on understanding its mechanisms, potential therapeutic applications, and safety profiles.In both primates and rodents, Adipotide has demonstrated remarkable efficacy in promoting rapid weight loss by eliminating fat stores. This groundbreaking compound exerts its effects by binding with high affinity to two key receptors: prohibitin and ANXA2, directly targeting fat cells.

Mechanism of Action: Adipotide targets a receptor called the “adipose tissue targeting” receptor, which is involved in the regulation of fat cell survival. By binding to this receptor, It can promote the death of adipocytes, leading to reduced fat mass.

Research: Initial studies, primarily in animal models, have shown that Adipotide can lead to significant weight loss and reductions in body fat without causing adverse effects on lean body mass. However, further research is needed to fully understand its effects and safety in humans.

Administration: It is typically administered via injection, and dosing regimens have varied in research settings.

Potential Applications: Beyond weight loss, there is interest in exploring Adipotide’s potential in treating obesity-related conditions, such as diabetes and metabolic syndrome.

Developed by a team of US scientists, Adipotide is intended solely for research applications, offering invaluable insights into the mechanisms of fat metabolism and weight regulation.

Adipotide Chemical Profile:

• Formula: C111H204N36O28S2
• Molecular Weight: 2555.22
• Peptide Purity: > 99.0%
• Chain: H-Cys-Lys-Gly-Gly-Arg-Ala-Lys-Asp-Cys-Gly-Gly-{D-Lys}-{D-Leu}-{D-Ala}-{D-Lys}-{D-Leu}-{D-Ala}-{D-Lys}-{D-Lys}-{D-Leu}-{D-Ala}-{D-Lys}-{D-Leu}-{D-Ala}-{D-Lys}-OH

Substance: Adipotide

Brand: Aviva Swiss

Dosage: 10 x 5mg

Experience the transformative potential of FT-TP and unlock new insights into fat loss research.

Disclaimer

You must be at least 21 years old to purchase. The use of this product is solely intended for research purposes; personal use is not condoned.  The information provided herein is not intended to substitute for medical advice, diagnosis, or treatment. Should any questions arise regarding a medical condition, it is recommended that advice be sought from a physician or qualified healthcare provider